Pr
Posted:
June 15, 2026
Location:
Seattle, WA, United States
Job Description
Providence Swedish Cancer Institute is seeking a full‑time, board‑certified/board‑eligible Medical Hematologist/Oncologist with a dedicated focus on hematologic malignancies to join a premier, multidisciplinary hematologic malignancy program in Seattle.
This is an exceptional opportunity to work within a nationally recognized cancer institute that offers comprehensive clinical care, robust clinical research infrastructure, and close collaboration with subspecialty teams across the Pacific Northwest.
**Practice Highlights:**
* Join a well‑established, high‑volume hematologic malignancy program with a strong regional referral base
* Work alongside a collaborative team of medical oncologists, hematologists, radiation oncologists, transplant specialists, APPs, nurses, pharmacists, and research staff
* Access to comprehensive services including cellular therapy, clinical trials, infusion services, advanced diagnostics, and supportive care programs
* Opportunities for invol...
This is an exceptional opportunity to work within a nationally recognized cancer institute that offers comprehensive clinical care, robust clinical research infrastructure, and close collaboration with subspecialty teams across the Pacific Northwest.
**Practice Highlights:**
* Join a well‑established, high‑volume hematologic malignancy program with a strong regional referral base
* Work alongside a collaborative team of medical oncologists, hematologists, radiation oncologists, transplant specialists, APPs, nurses, pharmacists, and research staff
* Access to comprehensive services including cellular therapy, clinical trials, infusion services, advanced diagnostics, and supportive care programs
* Opportunities for invol...
Apply for this Job
Submit your application for the Hematology Oncology Physician position at Provider Solutions & Development.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
Seattle, United States
Posted:
June 15, 2026
Deadline:
June 20, 2026